These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. Homocysteine-induced impairment of insulin secretion from clonal pancreatic BRIN-BD11 beta-cells is not prevented by catalase. Patterson S; Flatt PR; McClenaghan NH Pancreas; 2007 Jan; 34(1):144-51. PubMed ID: 17198197 [TBL] [Abstract][Full Text] [Related]
4. Prolonged exposure to homocysteine results in diminished but reversible pancreatic beta-cell responsiveness to insulinotropic agents. Patterson S; Scullion SM; McCluskey JT; Flatt PR; McClenaghan NH Diabetes Metab Res Rev; 2007 May; 23(4):324-34. PubMed ID: 17089371 [TBL] [Abstract][Full Text] [Related]
5. NMDA receptor inhibition increases, synchronizes, and stabilizes the collective pancreatic beta cell activity: Insights through multilayer network analysis. Šterk M; Križančić Bombek L; Skelin Klemen M; Slak Rupnik M; Marhl M; Stožer A; Gosak M PLoS Comput Biol; 2021 May; 17(5):e1009002. PubMed ID: 33974632 [TBL] [Abstract][Full Text] [Related]
6. Major metabolic homocysteine-derivative, homocysteine thiolactone, exerts changes in pancreatic beta-cell glucose-sensing, cellular signal transduction and integrity. Patterson S; Flatt PR; McClenaghan NH Arch Biochem Biophys; 2007 May; 461(2):287-93. PubMed ID: 17376398 [TBL] [Abstract][Full Text] [Related]
7. L-687,414, a low efficacy NMDA receptor glycine site partial agonist in vitro, does not prevent hippocampal LTP in vivo at plasma levels known to be neuroprotective. Priestley T; Marshall GR; Hill RG; Kemp JA Br J Pharmacol; 1998 Aug; 124(8):1767-73. PubMed ID: 9756395 [TBL] [Abstract][Full Text] [Related]
8. Evaluation of the insulin releasing and antihyperglycaemic activities of GPR55 lipid agonists using clonal beta-cells, isolated pancreatic islets and mice. McKillop AM; Moran BM; Abdel-Wahab YH; Flatt PR Br J Pharmacol; 2013 Nov; 170(5):978-90. PubMed ID: 23992544 [TBL] [Abstract][Full Text] [Related]
9. Acute and long-term effects of metformin on the function and insulin secretory responsiveness of clonal β-cells. McKiney JM; Irwin N; Flatt PR; Bailey CJ; McClenaghan NH Biol Chem; 2010 Dec; 391(12):1451-9. PubMed ID: 20868233 [TBL] [Abstract][Full Text] [Related]
10. Glutamate acts at NMDA receptors on fresh bovine and on cultured human retinal pigment epithelial cells to trigger release of ATP. Reigada D; Lu W; Mitchell CH J Physiol; 2006 Sep; 575(Pt 3):707-20. PubMed ID: 16809361 [TBL] [Abstract][Full Text] [Related]
11. Evaluation of the insulin-releasing and glucose-lowering effects of GPR120 activation in pancreatic β-cells. Moran BM; Abdel-Wahab YH; Flatt PR; McKillop AM Diabetes Obes Metab; 2014 Nov; 16(11):1128-39. PubMed ID: 24919766 [TBL] [Abstract][Full Text] [Related]
12. The role of N-methyl-D-aspartate receptor activation in homocysteine-induced death of retinal ganglion cells. Ganapathy PS; White RE; Ha Y; Bozard BR; McNeil PL; Caldwell RW; Kumar S; Black SM; Smith SB Invest Ophthalmol Vis Sci; 2011 Jul; 52(8):5515-24. PubMed ID: 21436276 [TBL] [Abstract][Full Text] [Related]
13. Enhancement of homocysteine toxicity to insulin-secreting BRIN-BD11 cells in combination with alloxan. Scullion SM; Gurgul-Convey E; Elsner M; Lenzen S; Flatt PR; McClenaghan NH J Endocrinol; 2012 Aug; 214(2):233-8. PubMed ID: 22582095 [TBL] [Abstract][Full Text] [Related]
14. [Effects of Ginkgo biloba extract against excitotoxicity induced by NMDA receptors and mechanism thereof]. Xiao ZY; Sun CK; Xiao XW; Lin YZ; Li S; Ma H; Song GR; Cheng R Zhonghua Yi Xue Za Zhi; 2006 Sep; 86(35):2479-84. PubMed ID: 17156678 [TBL] [Abstract][Full Text] [Related]
15. Developmental lead (Pb) exposure reduces the ability of the NMDA antagonist MK-801 to suppress long-term potentiation (LTP) in the rat dentate gyrus, in vivo. Gilbert ME; Lasley SM Neurotoxicol Teratol; 2007; 29(3):385-93. PubMed ID: 17350801 [TBL] [Abstract][Full Text] [Related]
16. Lowered brain stimulation reward thresholds in rats treated with a combination of caffeine and N-methyl-D-aspartate but not alpha-amino-3-hydroxy-5-methyl-4-isoxazole propionate or metabotropic glutamate receptor-5 receptor antagonists. Bespalov A; Dravolina O; Belozertseva I; Adamcio B; Zvartau E Behav Pharmacol; 2006 Jun; 17(4):295-302. PubMed ID: 16914947 [TBL] [Abstract][Full Text] [Related]
17. N-methyl-D-aspartate receptor antagonists are less effective in blocking long-term potentiation at apical than basal dendrites in hippocampal CA1 of awake rats. Leung LS; Shen B Hippocampus; 1999; 9(6):617-30. PubMed ID: 10641754 [TBL] [Abstract][Full Text] [Related]
18. Acute D-Serine Co-Agonism of β-Cell NMDA Receptors Potentiates Glucose-Stimulated Insulin Secretion and Excitatory β-Cell Membrane Activity. Lockridge A; Gustafson E; Wong A; Miller RF; Alejandro EU Cells; 2021 Jan; 10(1):. PubMed ID: 33430405 [TBL] [Abstract][Full Text] [Related]
19. Anticonvulsant action of both NMDA and non-NMDA receptor antagonists against seizures induced by homocysteine in immature rats. Folbergrová J Exp Neurol; 1997 Jun; 145(2 Pt 1):442-50. PubMed ID: 9217080 [TBL] [Abstract][Full Text] [Related]